Pharmaceuticals News and Research

RSS

Scientists receive critical funding to study treatments for three deadly cancers

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer.

17 Oct 2017

Study could pave way for more effective cancer therapies

Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism, which normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to take off one of these brakes.

17 Oct 2017

Mixed ad appeals lead to high medication empowerment among patients, study reveals

Autumn is flu season and that means it is high season for pharmacies selling over-the-counter cold and flu remedies. Those who aren't reminded by their own running noses are sure to be alerted to these types of pharmaceutical drugs by advertisements and posters.

17 Oct 2017

Cascade of costs could push new gene therapy above $1 million per patient

Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.

17 Oct 2017

Fluence Analytics launches new patented protein and polymer stability monitoring product

Fluence Analytics, a manufacturer of realtime, industrial and laboratory monitoring systems, today announced the launch of ARGEN, a patented protein and polymer stability monitoring product. By utilizing continuous light scattering measurements, ARGEN yields a unique information stream which reduces discovery and formulation and development times.

16 Oct 2017

Avantor opens new life sciences research and applications laboratory in South Korea

Avantor, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, recently opened a new life sciences research and applications laboratory in the GwangGyo district, Suwon, South Korea.

16 Oct 2017

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

Stand Up To Cancer has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.

13 Oct 2017

Phase 3 clinical trial for compound that shows promise in treatment of Rett syndrome

Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults.

13 Oct 2017

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.

12 Oct 2017

Study documents gene mutation as cause of cancer form in the liver

There is no effective treatment for the cancer form found in the liver called fibrolamellar hepatocellular carcinoma, which is mainly found among children and young people.

12 Oct 2017

Tai Chi may improve exercise behaviors in high-risk heart attack patients

The slow and gentle movements of Tai Chi hold promise as an alternative exercise option for patients who decline traditional cardiac rehabilitation, according to preliminary research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

11 Oct 2017

Exposure to environmental chemicals linked to development of breast cancer

Exposure to environmental chemicals, especially early in life, is an important contributing factor in the development of breast cancer, according to the most comprehensive review of human studies to date.

10 Oct 2017

Awards for contributions to analytical chemistry and applied spectroscopy announced by Pittcon

The Pittcon Program Committee is pleased to announce this year’s recipients of 13 prestigious awards honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each award will be presented in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory science, which will be held February 26-March 1, Orange County Convention Center, Orlando, Florida.

From Pittcon 10 Oct 2017

New law challenges ‘evils’ of pharma profits, California governor claims

California Gov. Jerry Brown defied the drug industry Monday by signing a sweeping drug price transparency bill that will force drugmakers to publicly justify big price hikes.

9 Oct 2017

Shifting toward novel pricing models that closely link drug's price to its value

One of the health care issues about which seemingly all Americans agree: Prescription drug prices have skyrocketed. And they keep going higher.

9 Oct 2017

Researchers develop new diagnostic and prognosis method for early detection of liver cancer

An international team of researchers at University of California San Diego School of Medicine and Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood sample containing circulating tumor DNA.

9 Oct 2017

Pharmaceuticals News and Research

Scientists receive critical funding to study treatments for three deadly cancers

Study could pave way for more effective cancer therapies

Mixed ad appeals lead to high medication empowerment among patients, study reveals

Cascade of costs could push new gene therapy above $1 million per patient

Fluence Analytics launches new patented protein and polymer stability monitoring product

Avantor opens new life sciences research and applications laboratory in South Korea

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

Phase 3 clinical trial for compound that shows promise in treatment of Rett syndrome

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Study documents gene mutation as cause of cancer form in the liver

Tai Chi may improve exercise behaviors in high-risk heart attack patients

Exposure to environmental chemicals linked to development of breast cancer

Awards for contributions to analytical chemistry and applied spectroscopy announced by Pittcon

New law challenges ‘evils’ of pharma profits, California governor claims

Shifting toward novel pricing models that closely link drug's price to its value

Researchers develop new diagnostic and prognosis method for early detection of liver cancer

Scientists discover how ZATT protein fixes DNA damage caused by cancer treatment

New topical treatment to combat skin cancer yields promising results in preliminary study

New webinar highlights importance of data integrity in GxP-regulated laboratories

Eyes fixed on California as governor ponders inking drug price transparency bill

Event guide: World ADC London eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring